SLC2A2 Knockout Huh-7 Cell Line
Cat.No.:
EDC07916
Species:
Human
Cell Name:
Huh-7
Gene:
SLC2A2
Gene ID:
6514
Size:
1×10⁶cells
SLC2A2 Knockout HuH-7 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07916 |
|---|---|
| Product Name | SLC2A2 Knockout HuH-7 Cell Line |
| Species | Human |
| Cell Line | Huh-7 |
| Cellosaurus ID | CVCL_0336 |
| Cell Line Synonyms | HuH-7, HUH-7, HuH7, Huh7, HUH7, HUH7.0, JTC-39, Japanese Tissue Culture-39 |
| Gene ID | |
| Gene | SLC2A2 |
| Summary |
This gene encodes an integral plasma membrane glycoprotein of the liver, islet beta cells, intestine, and kidney epithelium. The encoded protein mediates facilitated bidirectional glucose transport. Because of its low affinity for glucose, it has been suggested as a glucose sensor. Mutations in this gene are associated with susceptibility to diseases, including Fanconi-Bickel syndrome and noninsulin-dependent diabetes mellitus (NIDDM). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
|
| Associated Diseases | Hepatocellular Carcinoma |
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:4 |
| Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 70% complete culture medium+20% FBS+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: Huh-7 | STR Info (Cell bank) Cell Line: Huh-7 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 11 | 11 | ||
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 15 | ||
| D5S818 | 12 | 12 | ||
| D7S820 | 11 | 11 | ||
| D8S1179 | 14 | 14 | 15 | |
| D13S317 | 10 | 11 | 10 | 11 |
| D16S539 | 10 | 10 | ||
| D18S51 | 15 | 15 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 30 | 30 | ||
| FGA | 22 | 23 | 22 | 23 |
| Penta D | 12 | 12 | ||
| Penta E | 11 | 11 | ||
| TH01 | 7 | 7 | ||
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 16 | 18 | 16 | 18 |
| D6S1043 | 13 | 15 | 13 | 15 |
| D12S391 | 20 | 21 | 20 | 21 |
| D2S441 | 12 | 14 | 12 | 14 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC2A2 function, SLC2A2 Knockout Huh-7 Cell Line or SLC2A2 overexpression Huh-7 Cell Line?
The choice depends on whether you are studying SLC2A2 (GLUT2)'s role as the principal hepatic glucose transporter or modeling Fanconi-Bickel syndrome and diabetes-related glucose handling. The Knockout line is the standard tool for asking whether GLUT2 is required for bidirectional glucose transport — GLUT2 is the major glucose transporter in hepatocytes, pancreatic β-cells, and enterocytes, mediating both glucose uptake and release. Overexpression is useful for studying GLUT2 substrate selectivity (it transports glucose, fructose, galactose, and glucosamine).
For hepatic glucose research, the EDITGENE GLUT2 Knockout in Huh-7 is highly relevant — Huh-7 has hepatocellular origin and supports physiologically meaningful glucose transport studies. SLC2A2 mutations cause Fanconi-Bickel syndrome (hepatomegaly, renal Fanconi syndrome, glucose intolerance) — disease variant rescue enables genotype-function correlation studies. Rescue with wild-type or transport-deficient GLUT2 is the standard specificity control.
What are the application scenarios for this model?
Primary applications:
• Glucose uptake/release assays: ³H-2-deoxyglucose uptake and ³H-glucose efflux to characterize bidirectional GLUT2 transport.
• Substrate specificity: comparative uptake of glucose, fructose, galactose, and glucosamine to assess GLUT2's broad substrate scope.
• Fanconi-Bickel syndrome modeling: rescue with patient-derived SLC2A2 mutations for genotype-function correlation studies.
• Glucose sensing biology: studies of GLUT2's role in glucose-sensing functions in hepatocyte-derived contexts.
EDITGENE recommends this model for researchers investigating hepatic glucose transport biology, Fanconi-Bickel syndrome mechanisms, and GLUT family substrate specificity.
Is this SLC2A2 Knockout Huh-7 Cell Line compatible with overexpression rescue experiments?
Yes. GLUT2 rescue experiments are well-established in hepatic glucose biology:
• Construct design: use a codon-modified SLC2A2 sequence with a small C-terminal tag (FLAG, HA). GLUT2 has 12 transmembrane domains — preserve plasma membrane targeting determinants.
• Surface localization validation: confirm plasma membrane localization by cell surface biotinylation before glucose transport assays.
• Disease mutation rescue: Fanconi-Bickel syndrome-associated SLC2A2 mutations enable genotype-function studies.
• Functional readout: rescue should restore glucose, fructose, and galactose transport activities measured by radiolabel or LC-MS uptake assays.
Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation in a hepatocyte-derived background appropriate for GLUT2 functional studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download